Navigating Extrapulmonary Neuroendocrine Carcinoma: COR2ED Resource Featuring Insights from NECA CEO Meredith Cummins

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

ANZSNM 56th Annual Conference – Canberra (ACT), Australia

Nurses Workshop, Sunday, 17 May 2026

NECA Canberra NET Patient Forum, Saturday, 16 May 2026

NECA Joins Boehringer Ingelheim Panel Discussion on Clinical Trials and Patient Access

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.